Please assess the completion status of the following clinical trial:

Trial Title: Trial Evaluating Ambulatory Treatment of Travelers' Diarrhea

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~1. Active duty military or military beneficiary, 18 years-old or older.~2. Presence of acute diarrhea (3 or more stools in 24 hours or 2 or more stools in 24 hours and associated symptoms such as nausea, vomiting, abdominal cramps or tenesmus) and \<96 hours duration.~3. Eligible for ambulatory management.~4. Able to comply with follow-up procedures.~5. Will remain in country for at least 7 days~Exclusion Criteria:~1. Allergy to rifamycins, quinolones, macrolides, or loperamide (not including mild gastrointestinal upset).~2. Antibiotic therapy in the 72 hours prior to presentation (excluding malaria prophylaxis with mefloquine, malarone, chloroquine/proguanil, or doxycycline).~3. Concomitant medications with known drug-drug interactions with any of the study drugs (includes theophylline, digoxin, and warfarin).~4. History of seizures (relative contraindication to quinolones)~5. Positive pregnancy test at presentation (contraindicated with fluoroquinolone therapy). All female subjects will be administered a urine pregnancy test prior to enrollment.~6. Presence of symptoms \>96 hours prior to initiating treatment.~7. Use of \>4 mg loperamide or use of any amount of loperamide for greater than 24 hours prior to enrollment.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Acute Watery Diarrhea (Type: EXPERIMENTAL): None
- Acute Dysentery/Febrile (Type: EXPERIMENTAL): None

Based on this trial design, predict the completion outcome and termination type (if applicable).